After becoming the first COVID-19 vaccine in the world to be tested on children as young as 12 years, Covaxin is now going to be tested on children as young as two years, stated Bharat Biotech chairman and managing director Dr Krishna Ella.

A clinical trial is now being planned on children aged 2 to 15 years. A proposal will soon be submitted to the subject expert committee. Ella emphasized that Covaxin is an inactivated virus vaccine based on a tried and tested vero cell platform that has been used for several vaccines. Covaxin was the first among the COVID-19 vaccines to initiate testing on children(in September). Covaxin Phase II trials were conducted on 380 volunteers in September 2020 that included participants aged 12 to 65 years. The Pfizer vaccine started testing on 12-year-olds in October while Moderna started enroling participants aged 12 years and above in December… (ET Healthworld – TNN, January 5, 2021)